Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA- conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE

Irene Virgolini, Valentina Ambrosini, Jamshed B. Bomanji, Richard P. Baum, Stefano Fanti, Michael Gabriel, Nikolaos D. Papathanasiou, Giovanna Pepe, Wim Oyen, Clemens De Cristoforo, Arturo Chiti

Research output: Contribution to journalArticle

Abstract

The aim of these guidelines is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin (SST) receptor PET/CT imaging using 68Ga-DOTA-conjugated peptides, analogues of octreotide, that bind to SST receptors. This imaging modality should not be regarded as the only approach to visualizing tumours expressing SST receptors or as excluding other imaging modalities useful for obtaining comparable results. The corresponding guidelines of 111In- pentetreotide scintigraphy imaging have been considered and partially integrated with this text. The same has been done with the relevant and recent literature in this field and the final result has been discussed by distinguished experts.

Original languageEnglish
Pages (from-to)2004-2010
Number of pages7
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume37
Issue number10
DOIs
Publication statusPublished - Oct 2010

Keywords

  • Indications
  • Neuroendocrine tumours
  • Peptides
  • PET
  • Procedure guidelines
  • Tumour Imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA- conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE'. Together they form a unique fingerprint.

  • Cite this